IL80201A0 - Labdane derivatives,processes for their preparation and pharmaceutical compositions containing them - Google Patents

Labdane derivatives,processes for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL80201A0
IL80201A0 IL80201A IL8020186A IL80201A0 IL 80201 A0 IL80201 A0 IL 80201A0 IL 80201 A IL80201 A IL 80201A IL 8020186 A IL8020186 A IL 8020186A IL 80201 A0 IL80201 A0 IL 80201A0
Authority
IL
Israel
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
labdane derivatives
Prior art date
Application number
IL80201A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL80201A0 publication Critical patent/IL80201A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL80201A 1985-10-02 1986-09-30 Labdane derivatives,processes for their preparation and pharmaceutical compositions containing them IL80201A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853535086 DE3535086A1 (de) 1985-10-02 1985-10-02 Neue polyoxygenierte labdan-derivate, verfahren zu ihrer herstellung und ihre anwendung als medikamente

Publications (1)

Publication Number Publication Date
IL80201A0 true IL80201A0 (en) 1986-12-31

Family

ID=6282512

Family Applications (1)

Application Number Title Priority Date Filing Date
IL80201A IL80201A0 (en) 1985-10-02 1986-09-30 Labdane derivatives,processes for their preparation and pharmaceutical compositions containing them

Country Status (14)

Country Link
EP (1) EP0217372B1 (en, 2012)
JP (1) JPS6289677A (en, 2012)
KR (1) KR870004051A (en, 2012)
AT (1) ATE60054T1 (en, 2012)
AU (1) AU606036B2 (en, 2012)
DE (2) DE3535086A1 (en, 2012)
DK (1) DK468186A (en, 2012)
ES (1) ES2019863B3 (en, 2012)
GR (1) GR3001559T3 (en, 2012)
HU (1) HU203234B (en, 2012)
IL (1) IL80201A0 (en, 2012)
IN (2) IN163242B (en, 2012)
PT (1) PT83478B (en, 2012)
ZA (1) ZA867495B (en, 2012)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963537A (en) * 1985-03-01 1990-10-16 Hoechst-Roussel Pharmaceuticals Inc. Labdane compounds, pharmaceutical compositions and use
EP0193132B1 (en) * 1985-03-01 1991-04-17 Hoechst-Roussel Pharmaceuticals Incorporated Labdan-derivatives, a process for their preparation and their use as medicaments
JPS6310783A (ja) * 1985-11-15 1988-01-18 Nippon Kayaku Co Ltd 新規フオルスコリン誘導体
AU591196B2 (en) * 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
DE3623300A1 (de) * 1986-07-11 1988-01-21 Hoechst Ag 7-acyloxy-6-aminoacyloxypolyoxylabdane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5646175A (en) * 1987-12-28 1997-07-08 Hoechst Marion Roussel, Inc. Carbamoyloxylabdane compounds
US4920146A (en) * 1986-12-29 1990-04-24 Hoechst Roussel Pharmaceuticals Inc. Carbamoyloxylabdane compounds useful in reducing intraocular pressure
IN166900B (en, 2012) * 1987-06-03 1990-08-04 Hoechst India
JPH0684367B2 (ja) * 1987-06-29 1994-10-26 日本化薬株式会社 フオルスコリン誘導体の新規製造法
JP2504934B2 (ja) * 1987-06-29 1996-06-05 日本化薬株式会社 １，６，７−トリアシルフオルスコリン誘導体
US5846992A (en) * 1987-10-08 1998-12-08 Hoechst Marion Roussel, Inc. Synergistic intraocular pressure lowering combinations
US4902696A (en) * 1987-10-08 1990-02-20 Hoechst-Roussel Pharmaceuticals, Inc. Synergistic intraocular pressure lowering combinations
US4883793A (en) * 1988-05-09 1989-11-28 Hoechst-Roussel Pharmaceuticals Inc. Hydrazinocarbonyloxylabdanes for treating cardiac failure
EP0447962A1 (en) * 1990-03-17 1991-09-25 Hoechst Aktiengesellschaft Labdanes and process for their preparation
KR920002574A (ko) * 1990-07-24 1992-02-28 이젠브루크, 라피체 6-(3-치환된 아미노프로피오닐)-7-데아세틸포르스콜린 유도체의 제조방법
JP3557095B2 (ja) * 1998-04-20 2004-08-25 高砂香料工業株式会社 メラニン産生抑制剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557784C2 (de) 1975-12-22 1986-04-17 Hoechst Ag, 6230 Frankfurt Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate
DE2640275A1 (de) 1976-09-08 1978-03-09 Hoechst Ag Pharmakologisch wirksame substanz aus labiaten
DE2654796A1 (de) 1976-12-03 1978-06-08 Hoechst Ag Polyoxygenierte labdan-derivate
FR2460397A1 (fr) * 1979-07-05 1981-01-23 Ducellier & Cie Demarreur electrique pour moteurs a combustion interne notamment de vehicules automobiles
DE3581725D1 (de) * 1984-12-14 1991-03-14 Hoechst Roussel Pharma Aminoacyllabdane, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3502685A1 (de) 1985-01-26 1986-09-04 Hoechst Ag, 6230 Frankfurt Forskolin, seine analoge und derivate, verfahren zu deren herstellung mittels mikrobieller umwandlungen und die anwendung dieser verbindungen als arzneimittel
US4639443A (en) * 1985-03-01 1987-01-27 Hoechst-Roussel Pharmaceuticals Inc. Labdane compounds, pharmaceutical compositions and use
EP0193132B1 (en) * 1985-03-01 1991-04-17 Hoechst-Roussel Pharmaceuticals Incorporated Labdan-derivatives, a process for their preparation and their use as medicaments
AU591196B2 (en) * 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives

Also Published As

Publication number Publication date
HU203234B (en) 1991-06-28
PT83478B (pt) 1989-05-31
PT83478A (de) 1986-11-01
DE3535086A1 (de) 1987-04-16
EP0217372B1 (de) 1991-01-16
DK468186D0 (da) 1986-10-01
ES2019863B3 (es) 1991-07-16
AU6327086A (en) 1987-04-09
ATE60054T1 (de) 1991-02-15
EP0217372A2 (de) 1987-04-08
GR3001559T3 (en) 1992-11-23
DK468186A (da) 1987-04-03
AU606036B2 (en) 1991-01-31
ZA867495B (en) 1987-05-27
HUT46319A (en) 1988-10-28
EP0217372A3 (en) 1988-03-30
DE3676922D1 (de) 1991-02-21
KR870004051A (ko) 1987-05-07
IN164680B (en, 2012) 1989-05-06
IN163242B (en, 2012) 1988-08-27
JPS6289677A (ja) 1987-04-24

Similar Documents

Publication Publication Date Title
IL80201A0 (en) Labdane derivatives,processes for their preparation and pharmaceutical compositions containing them
ATE99302T1 (de) Substituierte flavonoide verbindungen, ihre salze, ihre herstellung und die enthaltende arnzeizusammensetzungen.
EP1225168A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
HUT42080A (en) Process for producing labdane derivatives and pharmaceutical compositions containing them
NO893135D0 (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
ES537205A0 (es) Procedimiento para preparar derivados de purina
DE3681581D1 (de) 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamine und 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamine.
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
ATE160349T1 (de) Antihypertensive benzopyran-derivate
IL58587A (en) Esters of 1,1,2-triphenylalkene derivatives,their preparation and pharmaceutical compositions comprising them
EP0207483A3 (en) Benzimidazoles, process for their preparation, medicaments containing them and intermediates
IE39049B1 (en) New 1,4-dihydroquinoline derivatives their production and their medicinal use
IT1241927B (it) 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono
EP0276805A3 (en) Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
FI871479A0 (fi) Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi
NO872982L (no) Nye tetracykliske indolderivater.
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav
FR2592653A1 (fr) Derives de chromene, procede d'obtention et compositions pharmaceutiques.
ATE30032T1 (de) N-acylderivate von dipeptiden, ihre herstellung und verwendung bei der therapie von krankheiten und mittel dafuer.
ES2106858T3 (es) Nuevos derivados de la citarabina, su procedimiento de preparacion y su uso contra enfermedades cancerosas.